Cercar

01/01/2022 Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a review
Sampedro, F, Kulisevsky, J. Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a review. JOURNAL OF NEUROIMAGING. 2022; 32(1)DOI:10.1111/jon.12930. PMID:34506674. IF:2.400(Q3/6D).
01/12/2021 Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington's disease
Sampedro, F, Martinez-Horta, S, Perez-Perez, J, Perez-Gonzalez, R, Horta-Barba, A, Campolongo, A, Aracil-Bolanos, I, Gomez-Anson, B, Kulisevsky, J. Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington's disease. Annals of Clinical and Translational Neurology. 2021; 8(12)DOI:10.1002/acn3.51460. PMID:34761569. IF:5.430(Q1/3D).
01/12/2021 The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
Aracil-Bolanos, I, Sampedro, F, Pujol, J, Soriano-Mas, C, Gonzalez-de-Echavarri, JM, Kulisevsky, J, Pagonabarraga, J. The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?. HUMAN BRAIN MAPPING. 2021; 42(17)DOI:10.1002/hbm.25650. PMID:34510640. IF:5.399(Q1/3D).
01/11/2021 Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson's Disease
Santos-Garcia, D, Castro, ES, Fonticoba, TD, Panceiras, MJF, Enriquez, JGM, Gonzalez, JMP, Bartolome, CC, Planellas, LL, Caldentey, JG, Caballol, N, Legarda, I, Lopez, IC, Manzanares, LL, Rivera, MAA, Catalan, MJ, Nogueira, V, Borrue, C, Sauco, MA, Vela, L, Cubo, E, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, MI, Kulisevsky, J, Pagonabarraga, J, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, Ardura, JG, Prieto, C, Mir, P, Martinez-Martin, P. Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson's Disease. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY. 2021; 34(6)DOI:10.1177/0891988720964250. PMID:33043810. IF:2.718(Q3/7D).
01/10/2021 Effects of a Green Oat Herb Extract on Cognitive Performance and Neurophysiological Activity: A Randomized Double-Blind Placebo-Controlled Study
Martinez-Horta, S, Ivanir, E, Perrinjaquet-Moccetti, T, Keuter, MH, Kulisevsky, J. Effects of a Green Oat Herb Extract on Cognitive Performance and Neurophysiological Activity: A Randomized Double-Blind Placebo-Controlled Study. Frontiers in Neuroscience. 2021; 15DOI:10.3389/fnins.2021.748188. PMID:34658781. IF:5.152(Q2/4D).
01/09/2021 Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson's disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysis
Pezzoli, S, Sanchez-Valle, R, Solanes, A, Kempton, MJ, Bandmann, O, Il Shin, J, Cagnin, A, Goldman, JG, Merkitch, D, Firbank, MJ, Taylor, JP, Pagonabarraga, J, Kulisevsky, J, Blanc, F, Verdolini, N, Venneri, A, Radua, J. Neuroanatomical and cognitive correlates of visual hallucinations in Parkinson's disease and dementia with Lewy bodies: Voxel-based morphometry and neuropsychological meta-analysis. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2021; 128DOI:10.1016/j.neubiorev.2021.06.030. PMID:34171324. IF:9.052(Q1/1D).
01/08/2021 Neural signatures of predictive language processing in Parkinson's disease with and without mild cognitive impairment
Leon-Cabrera, P, Pagonabarraga, J, Moris, J, Martinez-Horta, S, Marin-Lahoz, J, Horta-Barba, A, Bejr-Kasem, H, Kulisevsky, J, Rodriguez-Fornells, A. Neural signatures of predictive language processing in Parkinson's disease with and without mild cognitive impairment. CORTEX. 2021; 141DOI:10.1016/j.cortex.2021.03.032. PMID:34049254. IF:4.644(Q1/2D).
01/08/2021 Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi Project
Garcia, DS, Blazquez-Estrada, M, Calopa, M, Escamilla-Sevilla, F, Freire, E, Ruiz, PJG, Grandas, F, Kulisevsky, J, Lopez-Manzanares, L, Castrillo, JCM, Mir, P, Pagonabarraga, J, Perez-Errazquin, F, Salom, JM, Tijero, B, Valldeoriola, F, Yanez, R, Aviles, A, Luquin, MR. Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi Project. Brain Sciences. 2021; 11(8)DOI:10.3390/brainsci11081027. PMID:34439646. IF:3.333(Q3/7D).
08/07/2021 Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease
Alonso-Jimenez, A, Nunez-Peralta, C, Montesinos, P, Alonso-Perez, J, Garcia, C, Montiel, E, Belmonte, I, Pedrosa, I, Segovia, S, Llauger, J, Diaz-Manera, J. Different Approaches to Analyze Muscle Fat Replacement With Dixon MRI in Pompe Disease. Frontiers in Neurology. 2021; 12DOI:10.3389/fneur.2021.675781. PMID:34305788. IF:4.086(Q2/5D).
01/07/2021 In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study
Grothe, MJ, Labrador-Espinosa, MA, Jesus, S, Macias-Garcia, D, Adarmes-Gomez, A, Carrillo, F, Camacho, EI, Franco-Rosado, P, Lora, FR, Martin-Rodriguez, JF, Barbera, MA, Pastor, P, Arroyo, SE, Vila, BS, Foraster, AC, Martinez, JR, Padilla, FC, Morlans, MP, Aramburu, IG, Ceberio, JI, Vara, JH, de Fabregues-Boixar, O, Fonticoba, TD, Pascual-Sedano, B, Kulisevsky, J, Martinez-Martin, P, Santos-Garcia, D, Mir, P. In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study. PARKINSONISM & RELATED DISORDERS. 2021; 88DOI:10.1016/j.parkreldis.2021.05.027. PMID:34144230. IF:4.402(Q2/4D).
01/01/2023 Falls Predict Acute Hospitalization in Parkinson's Disease.
Santos García D, de Deus Fonticoba T, Cores C, Castro ES, Hernández Vara J, Jesús S, Mir P, Cosgaya M, Martí MJ, Pastor P, Cabo I, Seijo M, Legarda I, Vives B, Caballol N, Rúiz Martínez J, Croitoru I, Cubo E, Miranda J, Alonso Losada MG, Labandeira C, López Ariztegui N, Morales-Casado M, González Aramburu I, Infante J, Escalante S, Bernardo N, Blázquez Estrada M, Menéndez González M, Caldentey JG, Borrué C, Vela L, Catalán MJ, Gómez Mayordomo V, Kurtis M, Prieto C, Ordás C, Nogueira V, López Manzanares L, Ávila Rivera MA, Puente V, García Moreno JM, Solano Vila B, Álvarez Sauco M, Carrillo Padilla F, Carlos Martínez Castrillo J, Sánchez Alonso P, Gastón I, Kulisevsky J, Valero C, de Fábregues O, González Ardura J, López Díaz LM, Martinez-Martin P. Falls Predict Acute Hospitalization in Parkinson's Disease.. Journal of Parkinsons Disease. 2023; 13(1)DOI:10.3233/JPD-212539. PMID:33843696. IF:4.000(Q2/3D).
01/12/2022 Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington's Disease
Sampedro, F, Martinez-Horta, S, Perez-Perez, J, Perez-Gonzalez, R, Horta-Barba, A, Campolongo, A, Izquierdo, C, Aracil-Bolanos, I, Rivas, E, Puig-Davi, A, Pagonabarraga, J, Gomez-Anson, B, Kulisevsky, J. Plasma TDP-43 Reflects Cortical Neurodegeneration and Correlates with Neuropsychiatric Symptoms in Huntington's Disease. Clinical Neuroradiology. 2022; 32(4)DOI:10.1007/s00062-022-01150-5. PMID:35238950. IF:2.800(Q2/5D).
01/07/2022 Measuring the functional impact of cognitive impairment in Huntington's disease
Horta-Barba, A, Martinez-Horta, S, Perez-Perez, J, Sampedro, F, Puig-Davi, A, Pagonabarraga, J, Kulisevsky, J. Measuring the functional impact of cognitive impairment in Huntington's disease. JOURNAL OF NEUROLOGY. 2022; 269(7)DOI:10.1007/s00415-021-10955-2. PMID:35061089. IF:6.000(Q1/2D).
21/02/2022 Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus
Stocchi, F, Antonini, A, Berg, D, Bergmans, B, Jost, W, Katzenschlager, R, Kulisevsky, J, Odin, P, Valldeoriola, F, Chaudhuri, KR. Safinamide in the treatment pathway of Parkinson's Disease: a European Delphi Consensus. npj Parkinsons Disease. 2022; 8(1)DOI:10.1038/s41531-022-00277-z. PMID:35190544. IF:8.700(Q1/1D).
31/01/2022 Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders
Sampedro, F, Camara, E, Kulisevsky, J. Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.843440. PMID:35173676. IF:3.400(Q2/5D).
21/01/2022 Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data
Abdelnour, C, Ferreira, D, van de Beek, M, Cedres, N, Oppedal, K, Cavallin, L, Blanc, F, Bousiges, O, Wahlund, LO, Pilotto, A, Padovani, A, Boada, M, Pagonabarraga, J, Kulisevsky, J, Aarsland, D, Lemstra, AW, Westman, E. Parsing heterogeneity within dementia with Lewy bodies using clustering of biological, clinical, and demographic data. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-021-00946-w. PMID:35063023. IF:9.000(Q1/1D).
18/01/2022 Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study
Mauricio, D, Vlacho, B, de la Puente, JB, Mundet-Tuduri, X, Real, J, Kulisevsky, J, Ortega, E, Castelblanco, E, Julve, J, Franch-Nadal, J. Associations Between Diabetic Retinopathy and Parkinson's Disease: Results From the Catalonian Primary Care Cohort Study. Frontiers in Medicine. 2022; 8DOI:10.3389/fmed.2021.800973. PMID:35118094. IF:3.900(Q2/4D).
01/01/2022 An MDS Evidence-Based Review on Treatments for Huntington's Disease
Ferreira, JJ, Rodrigues, FB, Duarte, GS, Mestre, TA, Bachoud-Levi, AC, Bentivoglio, AR, Burgunder, JM, Cardoso, F, Claassen, DO, Landwehrmeyer, GB, Kulisevsky, J, Nirenberg, MJ, Rosser, A, Roth, J, Seppi, K, Slawek, J, Furr-Stimming, E, Tabrizi, SJ, Walker, FO, Vandenberghe, W, Costa, J, Sampaio, C. An MDS Evidence-Based Review on Treatments for Huntington's Disease. MOVEMENT DISORDERS. 2022; 37(1)DOI:10.1002/mds.28855. PMID:34842303. IF:8.600(Q1/1D).
01/01/2022 Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group
Garcia, DS, Roca, LG, Fonticoba, TD, Bartolome, CC, Rios, LN, Canfield, H, Gonzalez, JMP, Miro, CM, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P. Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group. Journal of Parkinsons Disease. 2022; 12(1)DOI:10.3233/JPD-212868. PMID:34602501. IF:5.200(Q1/3D).
01/01/2022 MNCD: A New Tool for Classifying Parkinson's Disease in Daily Clinical Practice
Garcia, DS, Sauco, MA, Calopa, M, Carrillo, F, Sevilla, FE, Freire, E, Ramos, RG, Kulisevsky, J, Esteban, JCG, Legarda, I, Luquin, MRI, Castrillo, JCM, Martinez-Martin, P, Martinez-Torres, I, Mir, P, Ignacio, AS. MNCD: A New Tool for Classifying Parkinson's Disease in Daily Clinical Practice. Diagnostics. 2022; 12(1)DOI:10.3390/diagnostics12010055. PMID:35054222. IF:3.600(Q2/4D).
01/01/2022 Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up
Santos García D, Canfield H, de Deus Fonticoba T, Cores Bartolomé C, Naya Ríos L, García Roca L, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz LM, McAfee D, Martinez-Martin P, Mir P, COPPADIS Study Group. Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. Journal of Parkinsons Disease. 2022; 12(3)DOI:10.3233/JPD-213004. PMID:34957949. IF:5.200(Q1/3D).
16/12/2021 Predictors of clinically significant quality of life impairment in Parkinson's disease
Garcia, DS, Fonticoba, TD, Cores, C, Munoz, G, Gonzalez, JMP, Miro, CM, Suarez, E, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Catalan, MJ, Nogueira, V, Puente, V, de Arcos, MR, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Clavero, P, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P. Predictors of clinically significant quality of life impairment in Parkinson's disease. npj Parkinsons Disease. 2021; 7(1)DOI:10.1038/s41531-021-00256-w. PMID:34916528. IF:9.304(Q1/1D).
08/12/2021 Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease
Martinez-Horta, S, Bejr-Kasem, H, Horta-Barba, A, Pascual-Sedano, B, Santos-Garcia, D, De Deus-Fonticoba, T, Jesus, S, Aguilar, M, Planellas, L, Garcia-Caldentey, J, Caballol, N, Vives-Pastor, B, Hernandez-Vara, J, Cabo-Lopez, I, Lopez-Manzanares, L, Gonzalez-Aramburu, I, Avila-Rivera, MA, Catalan, MJ, Lopez-Diaz, LM, Puente, V, Garcia-Moreno, JM, Borrue, C, Solano-Vila, B, Alvarez-Sauco, M, Vela, L, Escalante, S, Cubo, E, Carrillo-Padilla, F, Martinez-Castrillo, JC, Sanchez-Alonso, P, Alonso-Losada, MG, Lopez-Ariztegui, N, Gaston, I, Blazquez-Estrada, M, Seijo-Martinez, M, Ruiz-Martinez, J, Valero-Merino, C, Kurtis, M, De Fabregues-Boixar, O, Gonzalez-Ardura, J, Prieto-Jurczynska, C, Martinez-Martin, P, Mir, P, Kulisevsky, J. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease. BMC Neurology. 2021; 21(1)DOI:10.1186/s12883-021-02485-1. PMID:34879838. IF:2.903(Q3/7D).
01/12/2021 Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up
Garcia, DS, Rios, LN, Fonticoba, TD, Bartolome, CC, Roca, LG, Painceiras, MF, Miro, CM, Canfield, H, Jesus, S, Aguilar, M, Pastor, P, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Dotor, J, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JMC, Alonso, PS, Losada, MAG, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LLM, McAfee, D, Martinez-Martin, P, Mir, P. Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. Diagnostics. 2021; 11(12)DOI:10.3390/diagnostics11122380. PMID:34943619. IF:3.992(Q2/4D).
05/10/2021 Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Gaig, C, Compta, Y, Heidbreder, A, Marti, MJ, Titulaer, MJ, Crijnen, Y, Hogl, B, Lewerenz, J, Erro, ME, Garcia-Monco, JC, Nigro, P, Tambasco, N, Patalong-Ogiewa, M, Erdler, M, Macher, S, Berger-Sieczkowski, E, Hoftberger, R, Geis, C, Hutterer, M, Milan-Tomas, A, Martin-Bastida, A, Manzanares, LL, Quintas, S, Hoglinger, GU, Mohn, N, Schoberl, F, Thaler, FS, Asioli, GM, Provini, F, Plazzi, G, Berganzo, K, Blaabjerg, M, Bruggemann, N, Farias, T, Ng, CF, Giordana, C, Herrero-San Martin, A, Huebra, L, Kotschet, K, Liendl, H, Montojo, T, Morata, C, Perez, JP, Puertas, I, Seifert-Held, T, Seitz, C, Simabukuro, MM, Tellez, N, Villacieros-Alvarez, J, Willekens, B, Sabater, L, Iranzo, A, Cano, JS, Dalmau, J, Graus, F. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. NEUROLOGY. 2021; 97(14)DOI:10.1212/WNL.0000000000012639. PMID:34380749. IF:12.258(Q1/1D).
01/10/2021 A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Pagano, G, Boess, FG, Taylor, KI, Ricci, B, Mollenhauer, B, Poewe, W, Boulay, A, Anzures-Cabrera, J, Vogt, A, Marchesi, M, Post, A, Nikolcheva, T, Kinney, GG, Zago, WM, Ness, DK, Svoboda, H, Britschgi, M, Ostrowitzki, S, Simuni, T, Marek, K, Koller, M, Sevigny, J, Doody, R, Fontoura, P, Umbricht, D, Bonni, A, PASADENA Investigators, Bejr-Kasem, H, Bojarsky J.K., Prasinezumab Study Grp. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Frontiers in Neurology. 2021; 12DOI:10.3389/fneur.2021.705407. PMID:34659081. IF:4.086(Q2/5D).
01/09/2021 Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease
De Paepe, AE, Ara, A, Garcia-Gorro, C, Martinez-Horta, S, Perez-Perez, J, Kulisevsky, J, Rodriguez-Dechicha, N, Vaquer, I, Subira, S, Calopa, M, Munoz, E, Santacruz, P, Ruiz-Idiago, J, Mareca, C, de Diego-Balaguer, R, Camara, E. Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease. MOVEMENT DISORDERS. 2021; 36(9)DOI:10.1002/mds.28638. PMID:33998063. IF:9.698(Q1/1D).
01/08/2021 The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature
Pagonabarraga, J, Tinazzi, M, Caccia, C, Jost, WH. The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature. JOURNAL OF CLINICAL NEUROSCIENCE. 2021; 90DOI:10.1016/j.jocn.2021.05.056. PMID:34275546. IF:2.116(Q4/9D).
01/07/2021 Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up
Diego, SG, Teresa, DD, Cores, C, Canfield, H, Paz Gonzalez, JM, Miro, CM, Aymerich, LV, Suarez, E, Jesus, S, Aguilar, M, Pastor, P, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Hernandez-Vara, J, Cabo, I, Manzanares, LL, Aramburu, IG, Avila Rivera, MA, Catalan, MJ, Nogueira, V, Puente, V, Dotor, J, Borrue, C, Solano, B, Alvarez Sauco, M, Vela, L, Escalante, S, Cubo, E, Carrillo, F, Martinez Castrillo, JC, Alonso, PS, Alonso, G, Ariztegui, NL, Gaston, I, Kulisevsky, J, Blazquez, M, Seijo, M, Ruiz Martinez, J, Valero, C, Kurtis, M, de Fabregues, O, Ardura, J, Alonso, R, Ordas, C, Diaz, LML, McAfee, D, Martinez-Martin, P, Mir, P, COPPADIS Study Group. Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up. Journal of Personalized Medicine. 2021; 11(7)DOI:10.3390/jpm11070626. PMID:34209166. IF:3.508(Q2/4D).
01/11/2023 Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)
Dam, T, Golbe, LI, Hoglinger, GU, Grundman, M, Yang, LL, Tidemann-Miller, B, Kupferman, J, Harper, K, Kamisoglu, K, Wald, MJ, Graham, DL, Gedney, L, O'Gorman, J, Haeberlein, SB, Aiba, I, Antonini, A, Apetauerova, D, Azulay, JP, Martinez, EB, Bang, J, Barone, P, Barrett, M, Bega, D, Berg, D, Corrales, KB, Bordelon, Y, Boxer, AL, Brandt, M, Brueggemann, N, Castelnovo, G, Ceravolo, R, Chuang, RD, Chung, SJ, Church, A, Corvol, JC, Cudia, P, Dale, M, Defebvre, L, Drapier, S, Driver-Dunckley, ED, Ebersbach, G, Eggert, KM, Ellenbogen, A, Eusebio, A, Evans, AH, Fedorova, N, Finger, E, Foubert-Samier, A, Ghosh, B, Golbe, L, Perez, FG, Grossman, M, Hall, D, Hamada, K, Hasegawa, K, Hoeglinger, G, Honig, L, Houghton, D, Huang, XM, Isaacson, S, Koh, S, Bojarski, JK, Lang, ANE, Leigh, PN, Litvan, I, Lozano, JJL, Moreno, JLLS, Ludolph, AC, Piudo, MRL, Torres, IM, McFarland, N, Meissner, W, Mestre, T, Rivera, PM, Molho, E, Mollenhauer, B, Morris, HR, Murata, M, Obi, T, Magne, FO, O'Suilleabhain, P, Pahwa, R, Pantelyat, A, Pavese, N, Pokhabov, D, Prudlo, J, Rodriguez-Porcel, F, Rowe, J, Savitt, J, Schnitzler, A, Schulz, JB, Seppi, K, Shah, BI, Shill, H, Shprecher, D, Stamelou, M, Steiger, M, Takahashi, Y, Takigawa, H, Tartaglia, C, Toenges, L, Truong, D, Tse, W, Tuite, P, Volc, D, Wills, AMA, Woitalla, D, Xie, T, Yuasa, T, Zauber, SE, Zesiewicz, T. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021). NATURE MEDICINE. 2023; 29(11)DOI:10.1038/s41591-022-02076-8. PMID:36253611. IF:58.700(Q1/1D).
05/07/2023 Reduplicative paramnesia as an atypical form of presentation of a Heidenhain variant of Creutzfeldt-Jakob disease: A case report
Martinez-Horta, S, Marzal-Espi, CN, Cuso-Garcia, S, Aracil-Bolanos, I, Kulisevsky, J. Reduplicative paramnesia as an atypical form of presentation of a Heidenhain variant of Creutzfeldt-Jakob disease: A case report. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY. 2023; 29(6)DOI:10.1017/S1355617722000583. PMID:36062534. IF:2.600(Q2/4D).
01/03/2023 Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review
Rossi M., Hamed M., Rodríguez-Antigüedad J., Cornejo-Olivas M., Breza M., Lohmann K., Klein C., Rajalingam R., Marras C., van de Warrenburg B.P.. Genotype-Phenotype Correlations for ATX-TBP (SCA17): MDSGene Systematic Review. MOVEMENT DISORDERS. 2023; 38(3)DOI:10.1002/mds.29278. PMID:36374860. IF:7.400(Q1/1D).
01/01/2023 Non-Persistence of Tremorolytic Effect of Perampanel in Essential Tremor: Real-World Experience with 50 Patients
Gironell A., Pascual-Sedano B., Marín-Lahoz J., Pérez J., Pagonabarraga J.. Non-Persistence of Tremorolytic Effect of Perampanel in Essential Tremor: Real-World Experience with 50 Patients. Movement Disorders Clinical Practice. 2023; 10(1)DOI:10.1002/mdc3.13576. PMID:36704076. IF:2.600(Q2/5D).
01/01/2023 Autism Spectrum Disorder May Be Highly Prevalent in People with Functional Neurological Disorders
Gonzalez-Herrero, B, Morgante, F, Pagonabarraga, J, Stanton, B, Edwards, MJ. Autism Spectrum Disorder May Be Highly Prevalent in People with Functional Neurological Disorders. Journal of Clinical Medicine. 2023; 12(1)DOI:10.3390/jcm12010299. PMID:36615098. IF:3.000(Q1/2D).
01/12/2022 Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease
Sampedro, F, Martinez-Horta, S, Horta-Barba, A, Grothe, MJ, Labrador-Espinosa, MA, Jesus, S, Adarmes-Gomez, A, Carrillo, F, Puig-Davi, A, Roldan-Lora, F, Aguilar-Barbera, M, Pastor, P, Arroyo, SE, Vila, BS, Cots-Foraster, A, Ruiz-Martinez, J, Carrillo-Padilla, F, Pueyo-Morlans, M, Gonzalez-Aramburu, I, Infante-Ceberio, J, Hernandez-Vara, J, de Fabregues-Boixar, O, Fonticoba, TD, Avila, A, Martinez-Castrillo, JC, Bejr-Kasem, H, Campolongo, A, Pascual-Sedano, B, Martinez-Martin, P, Santos-Garcia, D, Mir, P, Garcia-Ruiz, PJ, Kulisevsky, J. Clinical and structural brain correlates of hypomimia in early-stage Parkinson's disease. EUROPEAN JOURNAL OF NEUROLOGY. 2022; 29(12)DOI:10.1111/ene.15513. PMID:35852918. IF:5.100(Q1/3D).
01/12/2022 Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers
Marin-Lahoz, J, Martinez-Horta, S, Pagonabarraga, J, Horta-Barba, A, Aracil-Bolanos, I, Bejr-kasem, H, Sampedro, F, Campolongo, A, Kulisevsky, J. Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers. ANNALS OF NEUROLOGY. 2022; 92(6)DOI:10.1002/ana.26486. PMID:36054656. IF:11.200(Q1/1D).
01/12/2022 Endothelial NO synthase 786T/T polymorphism increases hemorrhagic transformation after endovascular thrombectomy
De la Riva, P, Rodriguez-Antiguedad, J, Gomez, V, Arenaza, G, Gorostidi, A, Diez, N, De Arce, A, Martinez-Zabaleta, M, Gonzalez, F, Luttich, A, Garmendia, E, Sola, A, Larrea, JA, Bergareche, A, Sobrino, T. Endothelial NO synthase 786T/T polymorphism increases hemorrhagic transformation after endovascular thrombectomy. NITRIC OXIDE-BIOLOGY AND CHEMISTRY. 2022; 129DOI:10.1016/j.niox.2022.08.006. PMID:36067953. IF:3.900(Q2/5D).
01/11/2022 Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues
D'Acunzo, P, Kim, Y, Ungania, JM, Perez-Gonzalez, R, Goulbourne, CN, Levy, E. Isolation of mitochondria-derived mitovesicles and subpopulations of microvesicles and exosomes from brain tissues. Nature Protocols. 2022; 17(11)DOI:10.1038/s41596-022-00719-1. PMID:35962195. IF:14.800(Q1/1D).
01/11/2022 Risk of Parkinson's disease in a gout Mediterranean population: A case-control study
Pou, MA, Orfila, F, Pagonabarraga, J, Ferrer-Moret, S, Corominas, H, Diaz-Torne, C. Risk of Parkinson's disease in a gout Mediterranean population: A case-control study. JOINT BONE SPINE. 2022; 89(6)DOI:10.1016/j.jbspin.2022.105402. PMID:35504516. IF:4.200(Q2/5D).
01/10/2022 Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease
Saiz-Rodriguez, M, Gil-Polo, C, Diez-Fairen, M, Martinez-Horta, SI, Santalo, FS, Calvo, S, Alonso-Garcia, E, Rinones-Mena, E, Aguado, L, Mariscal, N, Munoz-Siscart, I, Pineiro, D, Rivadeneyra, J, Cubo, E. Polymorphisms in the oxytocin receptor and their association with apathy and impaired social cognition in Huntington's disease. NEUROLOGICAL SCIENCES. 2022; 43(10)DOI:10.1007/s10072-022-06226-1. PMID:35725858. IF:3.300(Q2/5D).